Residents of New Jersey may know that October is Breast Cancer Awareness Month, but they may not be aware that breast cancer affects men as well as women. The numbers are much smaller, of course, with some 2,200 men being diagnosed every year (compared to the 245,000 women who are diagnosed every year, according to the CDC). Still, there is concern around the fact that male breast cancer patients see lower survival rates than women.
One presenter at the 2019 Rheumatology Nurses Society Annual Conference, the president of the Independent Healthcare Associates, has warned that rheumatologists must beware when diagnosing patients who might have vasculitis. Vasculitis refers to the inflammation of the blood vessels. The problem is that various syndromes can result in this, raising the risk for misdiagnosis. New Jersey residents will want to know what can be done.
Believing that swift diagnosis of sepsis leads to the prevention and reduction of sepsis-related fatalities, the Survive Sepsis Campaign now requires diagnosis and antibiotic treatment within one hour of suspicion of sepsis infection. However, some researchers find no benefit from early administration of antibiotics. Only patients suffering from septic shock benefit from early intervention. Patients who are not definitely septic do not benefit from stringent antibiotic therapy. Timing seems to be critical in the diagnosis and treatment of sepsis.
Researchers have found that more and more people under the age of 50 are being diagnosed with colorectal cancer. New Jersey residents should know that the results, which were published in the peer-reviewed journal CANCER, are based on the cases gathered in the National Cancer Database. The number of colorectal cancer cases among younger people has been steadily growing since at least the 1970s.
According to a recent study from the Journal of Patient Safety, about 30% of malpractice claims related to electronic health records (EHR) involve medication errors. The research clearly showed that there were adverse effects to using electronic record-keeping at all types of health care practices in New Jersey and other states. However, most cases of malpractice occurred in an ambulatory setting, and the majority of these errors were due to user mistakes, not systematic issues.
When a medical patient is injured in New Jersey, the question arises as to whether the doctor was responsible. If the doctor did not follow the widely accepted standard for care in his or her field, then that may prove medical negligence, also known as medical malpractice. For a medical malpractice claim to work, though, a second element must be proven: that the negligence led to the injury. The two do not always go together.
New Jersey parents may have many fears when they take their children to the hospital, but few are likely to consider their medical records as a major area of concern. However, issues with the software and usability of electronic health records (EHRs) can sometimes lead to severe issues that can compromise patient safety. According to researchers, these risks are particularly profound for pediatric patients. Medication errors can be dangerous, especially when children are involved. Dosages must often be adjusted to account for their smaller size and younger age.
New Jersey patients who suffer from fibromyalgia often have to deal with widespread musculoskeletal pain. The fact that the disease is difficult to diagnose doesn't make the pain any easier. Now, a new study illustrates how often two diagnostic techniques are at odds with each other.
Stress can negatively impact how well surgeons in New Jersey perform. Even minor stressors can have a deleterious impact on surgical performance and might lead to medical mistakes. It is important for surgeons to take steps to reduce their stress and for hospitals to make changes to operating rooms so that they have fewer situations that produce it.
Misdiagnosis can be a serious concern for people in New Jersey with idiopathic pulmonary fibrosis. One company has announced that it is expanding an early access to a genetic test for the disorder, and it expects to make the test available across the country in 2019. By comparing genomic patterns from patients, the test allows physicians to differentiate between cases of IPF and other lung disorders.